Ganciclovir mediated regression of rat brain tumors expressing the herpes simplex virus thymidine kinase imaged by magnetic resonance
- 1 January 1995
- journal article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 24 (3), 259-265
- https://doi.org/10.1007/bf01052842
Abstract
Using a rat C6 brain tumor model, we studied the antitumor effects of Herpes simplex virus type 1 thymidine kinase (HSV-tk) gene transfer followed by ganciclovir treatment. C6 glioma cells were transfectedin vitro with the HSV-tk gene, and tested for their sensitivity to ganciclovir. Although there was no surviving cell at a 30 μM ganciclovir concentration, unmodified C6 cells were not affected by the drug. Forin vivo experiments, intracerebral tumors were induced in rats by stereotactic injection of 104 HSV-tk-modified C6 cells. Ten days later, the animals were treated with intraperitoneal injections of ganciclovir for 21 days. The tumors evolution was evaluated by high resolution magnetic resonance imaging. In 33% of the rats, the signal intensity of the tumors became heterogeneous, with development of highly hyperintense areas, and a complete tumor regression was subsequently noted. Histological examination of successfully treated tumors revealed progressive necrosis with formation of cysts. The survival time of the HSV-tk/ganciclovir treated animals was consistently increased, all rats surviving more than 30 days and 33% of them being still alive after 80 days.Keywords
This publication has 25 references indexed in Scilit:
- In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumorsJournal of Neurosurgery, 1994
- Thymidine kinase-mediated killing of rat brain tumorsJournal of Neurosurgery, 1993
- An experimental model of retrovirus gene therapy for malignant brain tumorsJournal of Neurosurgery, 1993
- Gene therapy of maliganant brain tumors: A rat glioma line bearing the herpes simplex virus type 1‐thymidine kinase gene and wild type retrovirus kills other tumor cellsJournal of Neuroscience Research, 1992
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase TransgeneHuman Gene Therapy, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- National survey of patterns of care for brain-tumor patientsJournal of Neurosurgery, 1989
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- An improved rat brain-tumor modelJournal of Neurosurgery, 1980